CRISPR-Based Therapeutic Approaches for Neurodegenerative Diseases¶
Analysis ID: SDA-2026-04-02-gap-crispr-neurodegeneration-20260402
Date: 2026-04-02
Domain: neurodegeneration
Hypotheses Generated: 5
Knowledge Graph Edges: 15
Key Hypotheses¶
- Base Editing of APOE4 to APOE2 in Astrocytes (score: 0.738)
- CRISPRi Silencing of Toxic Repeat Expansions (score: 0.701)
- CRISPR-Activated TREM2 Enhancement in Microglia (score: 0.668)
- Epigenome Editing to Restore Synaptic Gene Expression (score: 0.635)
- Prime Editing of APP Swedish Mutation (score: 0.612)
This notebook presents a computational analysis including differential gene expression, pathway enrichment, and multi-dimensional hypothesis scoring. Data is simulated based on known biology from the Allen Brain Cell Atlas (SEA-AD) and published literature.
1. Setup and Data Generation¶
Generated expression data for 20 genes x 5 cell types Samples per condition: 50
2. Differential Expression Heatmap¶
Log2 fold change of gene expression between AD and control samples across cell types. Significance: * p<0.05, ** p<0.01, *** p<0.001 (Mann-Whitney U test).
3. Volcano Plot: Microglia Expression¶
Differential expression in microglia — the primary immune cells of the brain. Red = upregulated in AD, blue = downregulated. Dashed line = p=0.05 threshold.
4. Statistical Analysis¶
Comprehensive statistical testing including non-parametric Mann-Whitney U tests, effect sizes (Cohen's d), and one-way ANOVA for cell-type variation.
5. Pathway Enrichment Analysis¶
Hypergeometric test for enrichment of hypothesis target genes in curated biological pathways (Reactome/KEGG-style). Identifies which molecular processes are overrepresented.
6. Hypothesis Multi-Dimensional Scoring¶
Top hypotheses scored across 6 key dimensions: mechanistic plausibility, evidence strength, novelty, feasibility, therapeutic impact, and druggability.
7. Knowledge Graph Edges¶
Causal relationships extracted from the multi-agent debate:
| Source | Relation | Target | Confidence |
|---|---|---|---|
| APOE4 | risk_factor | alzheimers_disease | 0.95 |
| CRISPR_base_editing | converts | APOE4_to_APOE2 | 0.82 |
| TREM2 | modulates | microglial_phagocytosis | 0.88 |
| CRISPRa | activates | TREM2 | 0.75 |
| APP | cleaved_by | BACE1 | 0.92 |
| C9orf72 | causes | ALS_FTD | 0.90 |
| CRISPRi | silences | repeat_expansion | 0.78 |
| SOD1 | therapeutic_target | ALS | 0.85 |
| GBA | risk_factor | parkinsons_disease | 0.80 |
| prime_editing | corrects | APP_Swedish_mutation | 0.70 |
| MAPT | forms | neurofibrillary_tangles | 0.88 |
| AAV9 | delivers | CRISPR_to_CNS | 0.72 |
| blood_brain_barrier | limits | CRISPR_delivery | 0.85 |
| off_target_effects | risk_of | CRISPR_therapy | 0.80 |
| PSEN1 | associated_with | familial_AD | 0.92 |
Total edges: 15
Methodology¶
This analysis was generated by SciDEX's multi-agent scientific debate system:
- Theorist generates novel hypotheses based on known biology
- Skeptic challenges assumptions and identifies weaknesses
- Domain Expert assesses druggability, feasibility, and clinical relevance
- Synthesizer ranks hypotheses and extracts knowledge graph edges
Gene expression data is simulated based on published SEA-AD atlas findings (Allen Institute for Brain Science).
Generated: 2026-04-02 23:46 UTC
Platform: SciDEX
Source: GitHub